Health Catalyst (HCAT) shares were down more than 2% in late Wednesday trading after Wells Fargo downgraded the stock to equalweight from overweight and lowered the price target to $1 from $5.
Trading volume stood at more than 1 million shares, compared with a daily average of 829,486.
Price: 1.15, Change: -0.02, Percent Change: -2.14